Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL study—authors' response. (20th September 2019) - Katlama, Christine; Assoumou, Lambert; Valantin, Marc-Antoine; Soulié, Cathia; Martinez, Esteban; Béniguel, Lydie; Bouchaud, Olivier; Raffi, François; Molina, Jean-Michel; Fellahi, Soraya; Peytavin, Gilles; Marcelin, Anne-Geneviève; et al.